Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Beta-blockers do not benefit heart attack patients with a normal LVEF
The new meta-analysis included data from nearly 18,000 patients. Overall, patient outcomes were quite similar for patients who did and did not undergo beta-blocker therapy.
Oral heart failure drug receives FDA’s fast track designation
A clinical trial focused on patients with HFpEF is expected to be completed by July 2026.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."

Unpaid student loan debt is bad for the heart

An American Journal of Preventive Medicine study highlights higher rates of cardiovascular disease for adults who fail to pay down student debt.

COVID-19 vaccine associated myocarditis on short-axis 1.5T MRI images of a 19-year-old man who presented with chest pain three days following the second dose of an mRNA COVID-19 vaccine.

New cardiac MRI analysis offers updated insight into long-term impact of vaccine-related myocarditis

Months after their initial myocarditis diagnosis, late gadolinium enhancement (LGE) was observed in 62% of patients on follow-up cardiac MRI.

Carotid endarterectomy (CEA) is not associated with a significant reduction in the risk of dementia, according to a new analysis published in the European Journal of Vascular & Endovascular Surgery.[1] However, the study’s authors noted, it did still lead to considerable improvements in stroke risk.

Carotid endarterectomy does not reduce long-term dementia risk

However, researchers noted, there was still a clear improvement in stroke risk.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes.

interventional cardiology heart failure cleveland clinic

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead.

Brugada arrhythmogenic substrate that causes VT and sudden cardiac death. This study showed ablation of this substrate area could help prevent sudden cardiac arrest in these patients.

Epicardial ablation in Brugada syndrome reduces sudden cardiac death

A late-breaking study at Heart Rhythm 2022 found epicardial ablation in Brugada syndrome helped significantly reduce sudden cardiac arrest in these patients, increasing their survival.

Veteran cardiologist Morton M. Mower, co-inventor of the automatic ICD, dies at 89

“I think he was the most brilliant person I’ve ever met," one long-time colleague said.

Clinical

Beta-blockers do not benefit heart attack patients with a normal LVEF

Oral heart failure drug receives FDA’s fast track designation

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring

Drones deliver AEDs for the first time in the United States